StudyPRN has been the dominant SCE question bank for over a decade, operated by LEARNA — a company that has built a substantial business from postgraduate medical education in the UK. For many registrars, StudyPRN is the default choice for SCE preparation simply because it has been around the longest and their seniors used it. But longevity is not the same as quality, and the medical education technology landscape has changed significantly since StudyPRN launched. This review assesses the platform honestly in 2026.
What StudyPRN offers
StudyPRN covers all 13 SCE specialties with dedicated question banks for each. Question counts range from approximately 450 (Geriatric Medicine) to 890 (Endocrinology and Diabetes), with most specialties sitting between 500 and 800 questions. The questions are written by named UK consultants — the platform prominently displays author credentials, and some specialty banks have been developed in collaboration with relevant medical societies, including the British Society for Rheumatology.
Each question includes an explanation that references clinical guidelines. The explanations are generally accurate and clinically appropriate, reflecting the consultant-level authorship. Some specialties also include supplementary learning notes alongside the question bank.
The platform offers timed mock exams for most specialties and basic performance tracking showing your overall percentage correct and progress through the question bank.
What StudyPRN does well
The strongest asset is credibility. Named consultant authors, society endorsements, and a decade of track record create genuine trust — particularly among IMG candidates for whom choosing a revision resource is a high-stakes decision. When you see that the Rheumatology bank was written by a named BSR-affiliated consultant, that carries weight.
The question quality is solid. The clinical vignettes are well-constructed, the distractors are plausible, and the explanations are clinically sound. For straightforward knowledge testing — "a patient presents with X, the most appropriate management is Y" — StudyPRN delivers reliably.
The breadth of specialty coverage is another strength. All 13 SCEs are covered under one umbrella, though you pay for each separately.
Where StudyPRN falls short
The most significant limitation is the absence of adaptive learning. Questions are delivered in sequential or random order with no algorithm adjusting to your performance. If you score 95 per cent on heart failure questions but 40 per cent on arrhythmia, the platform does not respond to that signal. You manage your own revision priorities manually, which requires discipline and self-awareness that most time-pressed registrars struggle to maintain.
There is no spaced repetition. Questions you answered three weeks ago are not scheduled for review at optimal intervals — they sit in your completed pile unless you manually revisit them. The cognitive science evidence for spaced repetition in medical education is robust, and its absence is a meaningful gap.
The mobile experience is a responsive website rather than a native app. It works on mobile browsers, but it is not optimised for touch interaction, offline access is not available, and the interface reflects a design language from an earlier era. For registrars who fit revision into commutes, coffee breaks, and on-call downtime — which is most registrars — the lack of a dedicated mobile app is a practical limitation.
Performance analytics are basic. You can see your overall percentage correct and your progress through the bank, but granular topic-level analysis is limited. You cannot easily identify which specific curriculum domains are weakest or track your accuracy trajectory over time across different topics.
The pricing model
StudyPRN charges per specialty with time-limited access. A three-month subscription typically costs between £79 and £199 depending on the specialty, with no cross-specialty access and no bundle pricing. If you want Cardiology and Respiratory, you pay for each separately. If you want to continue revising after your subscription expires, you pay again.
This pricing model made sense when StudyPRN was the only option, but it creates an unfavourable comparison in 2026. iatroX charges £29 per month or £99 per year for access to all 13 SCE specialties plus every other exam on the platform — MRCP, MRCPCH, MRCPsych, FRCA, MRCGP, PLAB, GPhC, ORE, MFDS, NDEB, RACP, and the specialist diplomas. A registrar paying £199 for three months of a single StudyPRN specialty could instead pay £87 for three months of iatroX and receive access to every exam bank on the platform.
For dual-accredited trainees, those preparing for multiple exams, or those who want continued access for CPD after their SCE, the value gap is substantial.
The LEARNA business context
LEARNA is not just StudyPRN — the company also operates diploma-msc.com (validated PgDip and MSc programmes) and learna.ac.uk (MBA courses). Companies House filings show substantial cash reserves and growth, indicating a profitable and stable business. This is relevant context because it means StudyPRN is unlikely to disappear — it is backed by a financially healthy parent company.
However, profitability can also breed complacency. When a product generates significant revenue from an established user base, the commercial incentive to invest in platform modernisation — adaptive algorithms, mobile apps, performance analytics — is weaker than the incentive to maintain the status quo. StudyPRN's functional limitations are consistent with a product that generates reliable revenue without needing to innovate.
Who should use StudyPRN
StudyPRN remains a credible choice for candidates who value named consultant authorship above all other factors, who have used the platform before and trust it, or who have institutional access through their training programme or hospital trust.
It is not the best choice for candidates who want adaptive learning, who need cross-specialty access, who study primarily on mobile devices, or who are price-sensitive. For these candidates — which in practice describes the majority of registrars in 2026 — iatroX offers a materially better product at a materially lower price.
The honest verdict
StudyPRN is a good question bank wrapped in a dated platform at a premium price. It will not let you down — the content is solid, the authors are credible, and thousands of registrars have passed their SCEs using it. But it is no longer the best option available. The absence of adaptive learning, spaced repetition, and modern performance analytics means you are paying more for less functionality than you can get elsewhere. The per-specialty pricing model compounds the problem for anyone who values flexibility.
If you are choosing an SCE question bank in 2026 on functionality and value, iatroX is the stronger choice. If you are choosing on brand familiarity and consultant authorship, StudyPRN retains an edge — though that edge narrows with every year it does not modernise.